Like all autoimmune diseases, those affecting the thyroid arise as the result of an interaction between genetic, environmental and endogenous factors. Genes outside the human leukocyte antigen (HLA) complex play a critical role, with recent associations described between a T cell surface receptor for the costimulatory signal B7 (provided by antigen presenting cells; CTLA-4), and interleukin-1 (IL-1) receptor antagonist polymorphisms and autoimmune thyroid disease. Birth weight and hormonal changes constitute important endogenous influences on susceptibility, while iodine intake, stress, infections and toxins are all environmental factors. Once initiated, events within the thyroid determine whether or not autoimmunity is maintained. Originally, HLA class II molecule expression by thyroid cells was thought to be a likely trigger in thyroid autoimmunity. However, thyroid cells cannot provide a necessary costi-mulatory signal, required in addition to class II molecule-mediated antigen presentation, making them incapable of initiating activation of autoreactive T cells. Moreover, class II-positive thyroid cells can induce peripheral tolerance in T cells and so class II expression can be viewed as a protective mechanism. Later, in established disease, costimulatory signals are not required by T cells for further stimulation, and class II expression could then exacerbate disease.

Keywords:
Graves’ disease, Hashimoto’s thyroiditis, Autoimmunity
This content is only available via PDF.
© 1997 S. Karger AG, Basel
1997
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.